Firefly Neuroscience, Inc.
AIFF
$2.24
$0.2613.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -90.08% | -173.31% | -455.24% | -600.69% | -301.84% |
| Total Depreciation and Amortization | 658.33% | 687.50% | 575.00% | -- | -- |
| Total Amortization of Deferred Charges | 47.27% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 234.77% | 399.63% | 5,671.59% | 5,230.00% | 1,185.76% |
| Change in Net Operating Assets | -365.62% | 66.34% | -708.90% | 75.28% | 227.21% |
| Cash from Operations | -33.13% | -39.65% | -136.40% | -125.51% | -183.38% |
| Capital Expenditure | 13.51% | -172.06% | -60.94% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.56% | 87.22% | 61.70% | 14.77% |
| Cash from Investing | -421.59% | -222.87% | -264.47% | 31.72% | -23.58% |
| Total Debt Issued | 29.46% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 157.36% | 27.45% | 250.62% | 193.27% | -4.70% |
| Repurchase of Common Stock | -2,739.51% | -- | -- | -- | -- |
| Issuance of Preferred Stock | 50.79% | 50.79% | -35.72% | -54.86% | -60.03% |
| Repurchase of Preferred Stock | -50.79% | 56.94% | -0.25% | 60.03% | 60.03% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 84.46% | 101.54% | 283.73% | 193.81% | 35.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 381.38% | 818.40% | 50,445.45% | 414.44% | -115.97% |